Trial Search Results
Characterization of Treatment Responses in Lymphedema
This study is designed to investigate the treatment response of lymphedema, of the upper or lower extremity, during clinical, pharmacologic treatment of lymphedema with oral ketoprofen. Correlation of clinical responses (changes in limb volume and skin thickness) with changes in the inflammasome will help to define the molecular substrate of treatment response.
Stanford is currently not accepting patients for this trial.
- Drug: Ketoprofen
- Participants with a history of acquired lymphedema
- Stage 1, 2, or 3
- 18-75 years
- Clinical use of ketoprofen for lymphedema
- Active cancer, infection, bleeding tendency, inflammatory disease and/or taking
anti-inflammatory medication will be excluded.
- Pregnant or lactating females
- Inability to take ketoprofen (contra-indicated, e.g patients with known CV, GI, renal,
Ages Eligible for Study
18 Years - 75 Years
Genders Eligible for Study